Speech-Language Pathologists in Tompkinsville, KY Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Kellimae C Page Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1148 Mount Gilead Rd, Tompkinsville, KY 42167 Phone: 270-407-9278

Michelle E Travis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1538 Cave Springs Rd, Tompkinsville, KY 42167 Phone: 270-576-1610

Mrs. Shaun Brantley Mcpherson, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 747 County House Rd, Tompkinsville, KY 42167 Phone: 270-434-2567    Fax: 270-434-2567

Rachel Rogan I, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 706 N Magnolia St, Tompkinsville, KY 42167 Phone: 270-487-6135

News Archive

Enigma ML, the fully automated Point-of-Care mini-laboratory instrument to be showcased

Enigma Diagnostics Limited, the decentralised point-of-care molecular diagnostics company, announces the showcasing of its fully automated Point-of-Care mini-laboratory instrument, the Enigma ML, at MEDICA 2009 at the Dusseldorf Trade Fair Centrehas in Dusseldorf, Germany in Hall 1, stand E07a between 18-20 November.

School Health honors Cardiac Science with prestigious Top Partner of the Year award

Fighting sudden cardiac arrest (SCA) in schools has been a business and social imperative for Cardiac Science since the company's founding. The reason is clear: Studies show that one in 50 high schools has had a SCA incident–either student or faculty–on school grounds each year–according to Parent Heart Watch, a CPR/AED Advocacy Group.

Tofacitinib safe and effective for patients with rheumatoid arthritis

Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.

Previewing inaugural Malaria Policy Advisory Committee

The Malaria Policy Advisory Committee, convened by the WHO Global Malaria Programme and composed of 15 malaria experts, will hold its first meeting January 31 through February 2 in Geneva, according to this article in Malaria Journal, which is a prelude to a series on the group's policy recommendations and supporting evidence that will be published following each biannual meeting.

Read more Medical News

› Verified 3 days ago